MLYS — Mineralys Therapeutics, Inc. Common Stock · $2.17B cap

Mineralys Therapeutics, Inc. Common Stock (MLYS) is a biotechnology company listed on US.

Use this MLYS page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the MLYS quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the MLYS SEC filings page. Lician reads the product cache first so this HTML stays unique to Mineralys Therapeutics, Inc. Common Stock even when a live quote feed is slow.